Bausch Health Companies BHC
NYSE BHC
$6.24 -0.19 (-3.03%)
As of: Sep 9, 2026 · 3:32 PM EDT

Bausch Health Companies (BHC) Amortization - Intangibles (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Amortization - Intangibles came in at $225.0 million in Q2 2026, down 12.11% year-over-year from $256.0 million in Q2 2025, and down 6.64% quarter-over-quarter from $241.0 million in Q1 2026.

Analysis

Bausch Health Companies (BHC) Amortization - Intangibles (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Amortization - Intangibles across 18 years of filings, most recently posting $225.0 million for Q2 2026.

  • In Q2 2026, Amortization - Intangibles fell 12.11% year-over-year to $225.0 million; the TTM figure through Jun 2026 stood at $955.0 million (down 8.61% YoY), while the FY2025 annual figure was $1.0 billion, down 7.06% from the prior year.
  • Amortization - Intangibles came in at $225.0 million for Q2 2026 at Bausch Health Companies, down from $241.0 million in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $313.0 million in Q4 2022 to a low of $225.0 million in Q2 2026.
  • Average Amortization - Intangibles over 5 years is $268.7 million, with a median of $269.5 million recorded in 2023.
  • Year-over-year, Amortization - Intangibles slipped 16.11% in 2022 and gained 8.3% in 2024.
  • Over 5 years, Amortization - Intangibles stood at $313.0 million in 2022, then slipped by 9.9% to $282.0 million in 2023, then slipped by 8.16% to $259.0 million in 2024, then slipped by 8.88% to $236.0 million in 2025, then decreased by 4.66% to $225.0 million in 2026.
  • Per Business Quant data, the three most recent Amortization - Intangibles figures were $225.0 million in Q2 2026, $241.0 million in Q1 2026, and $236.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.72 Bn 39.07 Bn 2.15 Bn
2 Viatris 19.14 Bn 18.26 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.89 Bn 9.71 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.46 Bn 5.34 Bn 334.51 Mn
5 Bausch Health Companies 2.33 Bn 494.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.48 Bn 1.12 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 994.43 Mn 704.31 Mn 93.47 Mn
9 Fennec Pharmaceuticals 399.34 Mn 358.09 Mn 17.15 Mn
10 RedHill Biopharma 178.33 Mn 178.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 225.00 Mn
Mar 31, 2026 241.00 Mn
Dec 31, 2025 236.00 Mn
Sep 30, 2025 253.00 Mn
Jun 30, 2025 256.00 Mn
Mar 31, 2025 256.00 Mn
Dec 31, 2024 259.00 Mn
Sep 30, 2024 274.00 Mn
Jun 30, 2024 270.00 Mn
Mar 31, 2024 274.00 Mn
Dec 31, 2023 282.00 Mn
Sep 30, 2023 253.00 Mn
Jun 30, 2023 269.00 Mn
Mar 31, 2023 273.00 Mn
Dec 31, 2022 313.00 Mn
Sep 30, 2022 290.00 Mn
Jun 30, 2022 302.00 Mn
Mar 31, 2022 310.00 Mn
Dec 31, 2021 320.00 Mn
Sep 30, 2021 338.00 Mn